CMIC Holdings Co Ltd
TSE:2309

Watchlist Manager
CMIC Holdings Co Ltd Logo
CMIC Holdings Co Ltd
TSE:2309
Watchlist
Price: 999 999.9999 JPY 37 893.92%
Market Cap: 47.6B JPY
Have any thoughts about
CMIC Holdings Co Ltd?
Write Note

CMIC Holdings Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CMIC Holdings Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
CMIC Holdings Co Ltd
TSE:2309
Income from Continuing Operations
ÂĄ5.6B
CAGR 3-Years
63%
CAGR 5-Years
30%
CAGR 10-Years
15%
C
Chiome Bioscience Inc
TSE:4583
Income from Continuing Operations
-ÂĄ1.2B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Medinet Co Ltd
TSE:2370
Income from Continuing Operations
-ÂĄ1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
2%
CellSource Co Ltd
TSE:4880
Income from Continuing Operations
ÂĄ923.1m
CAGR 3-Years
50%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Income from Continuing Operations
-ÂĄ121.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Income from Continuing Operations
ÂĄ857.8m
CAGR 3-Years
32%
CAGR 5-Years
29%
CAGR 10-Years
N/A
No Stocks Found

CMIC Holdings Co Ltd
Glance View

Market Cap
47.6B JPY
Industry
Life Sciences Tools & Services

CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Intrinsic Value
1 112 435.4753 JPY
Undervaluation 10%
Intrinsic Value
Price

See Also

What is CMIC Holdings Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
5.6B JPY

Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Income from Continuing Operations amounts to 5.6B JPY.

What is CMIC Holdings Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%

Over the last year, the Income from Continuing Operations growth was -36%. The average annual Income from Continuing Operations growth rates for CMIC Holdings Co Ltd have been 63% over the past three years , 30% over the past five years , and 15% over the past ten years .

Back to Top